Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 9, Issue 7, Pages 911-926
Publisher
Informa Healthcare
Online
2013-05-06
DOI
10.1517/17425255.2013.794785
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacodynamics of Itraconazole against Aspergillus fumigatus in anIn VitroModel of the Human Alveolus: Perspectives on the Treatment of Triazole-Resistant Infection and Utility of Airway Administration
- (2012) Zaid Al-Nakeeb et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance by Loss of Function of the Sterol Δ5,6-Desaturase Gene (ERG3) in Candida albicans Does Not Necessarily Decrease Virulence
- (2012) L. A. Vale-Silva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The T788G Mutation in thecyp51CGene Confers Voriconazole Resistance in Aspergillus flavus Causing Aspergillosis
- (2012) Wei Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole
- (2012) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus
- (2012) Paul Bowyer et al. FEMS MICROBIOLOGY LETTERS
- High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates
- (2012) A. Buied et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vivo Emergence of Aspergillus terreus with Reduced Azole Susceptibility and a Cyp51a M217I Alteration
- (2012) Maiken C. Arendrup et al. JOURNAL OF INFECTIOUS DISEASES
- Clonal Expansion and Emergence of Environmental Multiple-Triazole-Resistant Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in the cyp51A Gene in India
- (2012) Anuradha Chowdhary et al. PLoS One
- An Improved Model of the Aspergillus fumigatus CYP51A Protein
- (2011) M. G. Fraczek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature
- (2011) Simone M. T. Camps et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan
- (2011) Masato Tashiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in thecyp51AGene
- (2011) Shawn R. Lockhart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease
- (2011) David W. Denning et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
- (2011) Alison G. Freifeld et al. CLINICAL INFECTIOUS DISEASES
- Chitosan-coated liposomes for intracellular oligonucleotides delivery: Characteristics and cell uptake behavior
- (2011) Wen-Xi Wang et al. DRUG DELIVERY
- Peripheral neuropathy in patients on long-term triazole antifungal therapy
- (2011) C. G. Baxter et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India
- (2011) A. Chowdhary et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
- (2011) Brad Moriyama et al. MYCOSES
- A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14 -Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B
- (2010) C. M. Martel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain
- (2010) K. L. Mortensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Binding Properties of Candida albicans Sterol 14- Demethylase (CaCYP51)
- (2010) A. G. S. Warrilow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Posaconazole for Chronic Pulmonary Aspergillosis
- (2010) Timothy W. Felton et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
- (2010) John R. Perfect et al. CLINICAL INFECTIOUS DISEASES
- Clinical Evidence of Interaction Between Itraconazole and Nonnucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients with Disseminated Histoplasmosis
- (2009) Roberto A Andrade et al. ANNALS OF PHARMACOTHERAPY
- Three-Dimensional Model of Lanosterol 14 -Demethylase from Cryptococcus neoformans: Active-Site Characterization and Insights into Azole Binding
- (2009) C. Sheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes
- (2009) E. Dannaoui et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
- (2009) E. Snelders et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring
- (2009) Jodi M. Lestner et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility
- (2009) L. Yan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats1
- (2008) Jing DONG et al. ACTA PHARMACOLOGICA SINICA
- Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization
- (2008) David W. Denning et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America
- (2008) Stanley W. Chapman et al. CLINICAL INFECTIOUS DISEASES
- Therapeutic drug monitoring for triazoles
- (2008) William W Hope et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Cardiovascular adverse effects during itraconazole therapy
- (2008) S-L. Fung et al. EUROPEAN RESPIRATORY JOURNAL
- Itraconazole Oral Solution Enhanced Vincristine Neurotoxicity in Five Patients with Malignant Lymphoma
- (2008) Naoto Takahashi et al. INTERNAL MEDICINE
- Development and evaluation of novel itraconazole-loaded intravenous nanoparticles
- (2008) Wei Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species
- (2008) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
- (2008) Eveline Snelders et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started